Literature DB >> 3803732

Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark.

A Kofoed-Enevoldsen, K Borch-Johnsen, S Kreiner, J Nerup, T Deckert.   

Abstract

The decreasing relative mortality among type I (insulin-dependent) diabetic patients during the last 50 years might be related to the incidence of clinical diabetic nephropathy. We therefore followed 2890 type I diabetic patients (1607 males and 1283 females) diagnosed between 1933 and 1972 and before the age of 31, from admission to death, emigration, or January 1, 1984. All patients had been admitted to the Steno Memorial Hospital. Information on development of proteinuria was obtained in 2658 patients (92%). Five hundred twenty-five patients developed proteinuria due to diabetes and 49 developed nondiabetic proteinuria. When comparing patients diagnosed between 1933 and 1942 with those diagnosed between 1953 and 1962, the incidence of proteinuria decreased by 30% (P less than .03). This might explain the decrease of relative mortality in type I diabetic patients. The incidence decreased with increasing age at onset but was always highest in males. Insulin dose (U/kg) and diabetes duration at admission did not influence the incidence of proteinuria. The incidence peaked after 15-17 yr of diabetes duration independent of sex, age at diagnosis, or calendar year of diagnosis. However, the majority of patients did not develop proteinuria during 40 yr of diabetes. This suggests individual renal susceptibility to the deleterious effect of hyperglycemia.

Entities:  

Mesh:

Year:  1987        PMID: 3803732     DOI: 10.2337/diab.36.2.205

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  30 in total

1.  Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study.

Authors:  M Nordwall; M Bojestig; H J Arnqvist; J Ludvigsson
Journal:  Diabetologia       Date:  2004-07-02       Impact factor: 10.122

2.  The economics of screening for microalbuminuria in patients with insulin-dependent diabetes mellitus.

Authors:  K Borch-Johnsen
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

Review 3.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 4.  Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history.

Authors:  Peter Rossing
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 5.  Type 1 diabetes in the young: the harvest of sorrow goes on.

Authors:  E A M Gale
Journal:  Diabetologia       Date:  2005-08       Impact factor: 10.122

Review 6.  Epidemiology of diabetes and diabetes-related complications.

Authors:  Anjali D Deshpande; Marcie Harris-Hayes; Mario Schootman
Journal:  Phys Ther       Date:  2008-09-18

Review 7.  The role of hypertension in the development of nephropathy in type 1 (insulin-dependent) diabetes mellitus.

Authors:  B Feldt-Rasmussen; K Nørgaard; T Jensen; E Mathiesen; T Deckert
Journal:  Acta Diabetol Lat       Date:  1990 Apr-Jun

Review 8.  Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.

Authors:  Tsuneharu Baba; Takashi Ishizaki
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 9.  C-peptide: a new potential in the treatment of diabetic nephropathy.

Authors:  J Wahren; K Ekberg; B Samnegård; B L Johansson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

10.  Relationship between early metabolic control and the development of microalbuminuria--a longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus.

Authors:  S Rudberg; E Ullman; G Dahlquist
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.